Statistics
Publications
21
Citations
1.1K
H-Index
21
Active since
1989
Peter Spacciapoli is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, pharmacology, and pharmacy.
Publications per year
1989–2021
21
21
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit
Johnny E. Kopinja, Raquel Sevilla, Diane Levitan et al. · Scientific Reports · 2017 · 52 citations · Full text
Medicine, Oncology, Pharmacology +9
1–5 of 21